SCHEMBL7020411

SCHEMBL7020411

Nc1cc(Oc2ccc(Cl)cn2)c(Cl)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
GRM4 Q14833 2/20 0.42
GRM8 O00222 1/20 0.42
GRM7 Q14831 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.40
MPO P05164 1/20 0.37
TPO P07202 1/20 0.37
EPX P11678 1/20 0.37
LPO P22079 1/20 0.37
KDM4E B2RXH2 3/20 0.37
POLB P06746 2/20 0.37
ALOX5AP P20292 2/20 0.35
FEN1 P39748 2/20 0.35
HSPB1 P04792 1/20 0.35
RXRA P19793 3/20 0.34
GRIN1 Q05586 3/20 0.34
GRIN2B Q13224 3/20 0.34
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7021570 0.86 KMT2A (0.41) KMT2AMEN1L3MBTL1MPOTPO
SCHEMBL7012959 0.82 ALOX5AP (0.50) KMT2AMEN1GRM4MPOTPO
SCHEMBL2853578 0.80 HSPB1 (0.60) KMT2AMEN1L3MBTL1KDM4EPOLB
SCHEMBL7020782 0.79 KDM4E (0.41) KMT2AMEN1GRM4GRM8GRM7
SCHEMBL25275508 0.78 MEN1 (0.55) KMT2AMEN1GRM4GRM8GRM7
SCHEMBL30466069 0.78 MEN1 (0.55) KMT2AMEN1GRM4GRM8GRM7
SCHEMBL1148984 0.77 GRM4 (0.50) KMT2AMEN1GRM4GRM8GRM7
SCHEMBL3351203 0.74 HSPB1 (0.59) KMT2AMEN1GRM4GRM8GRM7
SCHEMBL7019302 0.73 MAPT (0.38) KMT2A
SCHEMBL7014869 0.73 GRM4 (0.38) KMT2AGRM4L3MBTL1MPOTPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0973395-B1 DIARYL ETHERS AND PROCESSES FOR THEIR PREPARATION AND HERBICIDAL AND DESICCANT COMPOSITIONS CONTAINING THEM ISK AMERICAS INC (US) 2003-12-03 EP disclosed
US-6479435-B1 OR DIARYL SULFIDES, 1-(4-CHLORO-2-FLUORO-5-(2-PYRIMIDYLOXY)PHENYL)-4-DIFLUOROMETHY L-3-METHYL-1,4-DIHYDRO-1,2,4-TRIAZOLIN-5-ONE FOR EXAMPLE ISK AMERICAS INCORPORATED 2002-11-12 US disclosed
US-20020161224-A1 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them PULMAN DAVID A (US) 2002-10-31 US disclosed
US-6333296-B1 FOR CONTRILLING WEEDS ISK AMERICAS INCORPORATED 2001-12-25 US disclosed
US-6303543-B1 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them ISHIHARA SANGYO KAISHA, LTD. (JP) 2001-10-16 US disclosed
EP-0973395-A4 DIARYL ETHERS AND PROCESSES FOR THEIR PREPARATION AND HERBICIDAL AND DESICCANT COMPOSITIONS CONTAINING THEM ISK AMERICAS INC (US) 2001-10-04 EP disclosed
US-6121201-A HETEROARYL SUBSTITUTED HALO-PYRAZOLE SUBSTITUTED DIARYL ETHERS OR THIOETHERS ISHIHARA SANGYO KAISHA, LTD. (JP) 2000-09-19 US disclosed
EP-0973395-A1 DIARYL ETHERS AND PROCESSES FOR THEIR PREPARATION AND HERBICIDAL AND DESICCANT COMPOSITIONS CONTAINING THEM ISK Americas Incorporated (US) 2000-01-26 EP disclosed
WO-1998041093-A1 DIARYL ETHERS AND PROCESSES FOR THEIR PREPARATION AND HERBICIDAL AND DESICCANT COMPOSITIONS CONTAINING THEM ISK AMERICAS INCORPORATED (US) 1998-09-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020161224-A1 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them HDHD5, DDT, CBR3 KMT2A 1350/4885MEN1 4038/4885GRM4 3701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.